论文部分内容阅读
治疗脑动静脉畸形的丁氰酯(简称 IBCA)临床应用于10月8日在解放军总医院通过技术鉴定。脑动静脉畸形通常采用手术切除的方法进行治疗,但有些由于部位深,畸形巨大,难以进行手术,死亡率很高。丁氰酯是一种低粘度的血管内拴塞剂,可以迅速聚合,永久存留,是目前世界上公认的最佳血管内栓塞剂。解放军总医院参照国外样品,独
The treatment of cerebral arteriovenous malformations of butyronitrile (IBCA) clinical application on October 8 in the People’s Liberation Army General Hospital through technical appraisal. Cerebral arteriovenous malformations are usually treated by surgical excision, but some are difficult to carry out due to the deep site and deformity. The mortality rate is high. Butyryl cyanoacrylate is a low-viscosity intravascular plugging agent that can be rapidly polymerized and persisted. It is the best endovascular embolization agent in the world. People’s Liberation Army General Hospital reference to foreign samples, alone